MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
SKINDEX questionnaire


Developed by:
Mary-Margaret Chren (USA)

Objective:
To measure the effects of skin disease on patients' quality of life.

Copyright:
For the Skindex: Skindex© MM Chren, 1996
For the Skindex-16: Skindex© The Regents of the University of California, 2001
For the Skindex-29: Skindex© MM Chren, 1997

Reference publications:
Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Sindex, a quality-of-life measure for patients with skin disease: reliability, validity and responsiveness. J Invest Dermatol. 1996 Nov;107(5):707-13

Chren MM, Lasek RJ, Flock SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997 Nov;133:1433,1440

Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement of properties of skindex-16, a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001 Mar-Apr;5(2):105-10. Epub 2001 Mar 21.


Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions required by the Author are detailed.

Skindex-16 User-Agreement
Skindex-29 User Agreement

2. Access Fees:

Distribution fees are requested according to the context of use and User's profile:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study and per version + 50 €* per language version

- In commercial studies (3) involving "for-profit" organizations: 700 €* per study and per version + 250 €* per language version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Review copy:


Original US English version of the Skindex-16 available for review purpose only. Please click here to access.

Original US English version of the Skindex-29 available for review purpose only. Please click here to access.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on Skindex on PROQOLID

[ BACK ]

 

To access our catalog, please click here.

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
MAPI SAS / Registrat MAPI (France)

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index questionnaire
The Maryland State Medical Society - MedChi (USA)

ESS (Epworth Sleepiness Scale) 
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK) & Claudia Trenkwalder (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)